期刊文献+

心钠素基因的突变及对其利尿活性的影响 被引量:1

Site-directed mutagenesis of atrial natriuretic peptide gene and effect of the mutations on its diuretic activity in nephrotic rats
原文传递
导出
摘要 目的 提高心钠素的生物学活性。方法 通过改造心钠素基因、构建突变型心钠素基因的逆转录病毒载体以及用肌内注射法将突变型和非突变型心钠素基因表达载体的裸DNA分别导入阿霉素诱导的肾病大鼠体内 ,以对其突变前后的利尿活性进行比较研究。结果 获得了结构和功能两方面均符合预期的突变型心钠素基因。与空载体组相比 [87± 7 1pg/ml(n =6 ) ],突变和野生型心钠素基因组大鼠 (n =6 )血浆中的心钠素浓度均在试验开始后的第 5d明显升高 ,分别为 10 7± 7 8pg/ml(t =4 6 5 ,P <0 0 1)和 113± 8 6pg/ml(t =5 71,P <0 0 1)。两个试验组大鼠的尿量在试验开始后的第 5d就明显增多 ,有效期达 15d以上。突变型心钠素基因的作用更强 ,其大鼠在第 5、10和 15d时的尿液增长量分别是野生型心钠素组的 1 6、2 0和 1 9倍。结论 所获突变型心钠素基因的利尿作用明显增强。 Objective To prolong the half-life and enhance the biological activity of the human atrial natriuretic peptide (hANP), a peptide hormone, which is synthesized and released mainly by cardiac atrial myocytes and possesses potent natriuretic, diretic, and vasorelaxant properties Methods The site-directed mutation technique based on polymerase chain reaction was performed to get the mutant of the human ANP gene (mhANP), and the retroviral expression vector, pLHY24, in which mhANP gene is under the transcriptional control of the human cytomegalovirus promoter, was constructed The naked plasmid DNA of pLHY24 and positive control vector, pLHY19, in which the wild-type hNAP gene is in the same conditions as mhANP gene in pLHY24, and negative control vector, pLNCX without purpose gene, at a dose of 5 mg/kg body weight was injected intramuscularly into the rats with experimental renal disorder induced with adriamycin (ADR), respectively Results DNA sequencing result proved that the respected mhANP gene with the point mutations of TTC 131/Phe→TCC/Ser and ATG 135/Met→ATA/Ile has been obtained In comparison with negative control group (87 ±7 1 pg/ml), a single intramuscular injection of expression vector harboring mhANP or hANP gene resulted in an obvious increase in plasma level of mhANP (107 ±7 8 pg/ml, t = 4 65, P<0 01) or hANP (113 ±8 6 pg/ml, t = 5 71, P<0 01) 5 days after injection A significant elevation in the ratio of urine volume to body weight was occurred after both of mhANP gene and hANP gene delivery as compared with negative control and the effect lasted for more than 15 days The diuretic activity of mhANP gene delivery was 1 6-, 2 0-, and 1 9-fold higher than that of hANP gene 5, 10, and 15 days after gene transfer, respectively However, there were no statistical differences in the concentrations of K+ and Na+ in urine Conclusions Both of mhANP and hANP gene delivery into the rats with experimental nephropathy could improve their directic function obviously and the diuretic activity of the former is stronger than that of the latter significantly
出处 《中华医学杂志》 CAS CSCD 北大核心 2002年第19期1324-1327,共4页 National Medical Journal of China
基金 国家攀登计划资助项目 (93 0 2 110 0 3 )
关键词 利尿活性 心钠素 基因疗法 逆转录病毒载体 心力衰竭 Atrial natriuretic factor Gene therapy Retroviral vector
  • 相关文献

参考文献9

  • 1Maack T. Roles of atrial natriuretic factor in volume control. Kidney Int, 1996, 49:1732-1737.
  • 2Yoshimura M, Yasue H, Ogawa H. Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure. Can J Physiol Pharmacol, 2001, 79:730-735.
  • 3Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science, 1990, 247(4949 Pt 1):1465-1468.
  • 4Chao J, Jin L, Chen LM, et al. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hum Gene Ther, 1996, 7:901-911.
  • 5敖朝晖. 多聚酶链式反应(PCR)技术. 见: 卢圣栋, 主编. 现代分子生物学实验技术. 北京: 高等教育出版社, 1993. 408-429.
  • 6Valentin JP, Ying WZ, Couser WG, et al. Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome. Am J Physiol, 1998, 274(3 Pt 2):F556-563.
  • 7Jespersen B, Eiskjaer H, Mogensen CE, et al. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate. Nephron, 1995, 71:44-53.
  • 8Veress AT, Chong CK, Field LJ, et al. Blood pressure and fluid-eletrolyte balance in ANF-transgenic mice on high- and low-salt diets. AM J Physiol, 1995, 269(1 Pt 2):R186-R192.
  • 9John SW, Krege JH, Oliver PM, et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science, 1995, 267: 679-681.

同被引文献3

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部